Trial Profile
A study of switching from rHuEPO to intravenous R744 in renal anemia patients on hemodialysis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 25 May 2016 New trial record